Publication | Closed Access
Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia
26
Citations
15
References
2016
Year
Time to LTR was significantly longer with pregabalin CR than with placebo. Safety profile of pregabalin CR was comparable to that reported for the immediate-release formulation in patients with postherpetic neuralgia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1